The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology ; volume:9 ; number:1 ; day:26 ; month:4 ; year:2017 ; pages:1-11 ; date:12.2017
Alzheimer's research & therapy ; 9, Heft 1 (26.4.2017), 1-11, 12.2017
- Schlagwort
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Urheber
-
Westwood, Sarah
- Beteiligte Personen und Organisationen
-
Liu, Benjamine
Baird, Alison L.
Anand, Sneha
Nevado-Holgado, Alejo J.
Newby, Danielle
Pikkarainen, Maria
Hallikainen, Merja
Kuusisto, Johanna
Streffer, Johannes R.
Novak, Gerald
Blennow, Kaj
Andréasson, Ulf
Zetterberg, Henrik
Smith, Ulf
Laakso, Markku
Soininen, Hilkka
Lovestone, Simon
SpringerLink (Online service)
- DOI
-
10.1186/s13195-017-0258-6
- URN
-
urn:nbn:de:1111-2017050889
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Westwood, Sarah
- Liu, Benjamine
- Baird, Alison L.
- Anand, Sneha
- Nevado-Holgado, Alejo J.
- Newby, Danielle
- Pikkarainen, Maria
- Hallikainen, Merja
- Kuusisto, Johanna
- Streffer, Johannes R.
- Novak, Gerald
- Blennow, Kaj
- Andréasson, Ulf
- Zetterberg, Henrik
- Smith, Ulf
- Laakso, Markku
- Soininen, Hilkka
- Lovestone, Simon
- SpringerLink (Online service)
Ähnliche Objekte (12)
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium